Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01477060
Recruitment Status : Terminated (The study was stopped due to insufficient accrual)
First Posted : November 22, 2011
Last Update Posted : February 20, 2014
Information provided by (Responsible Party):
Fondazione Michelangelo

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013